David J. Maloney
Oprichter bij Veralox Therapeutics, Inc.
Profiel
David J.
Maloney is the founder of Veralox Therapeutics, Inc. (founded in 2017) where he holds the title of Chief Scientific Officer.
In 2017, he worked as Vice President & Head-Translational Medicine at Rebus Holdings, Inc. Dr. Maloney holds a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
Actieve functies van David J. Maloney
Bedrijven | Functie | Begin |
---|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Oprichter | 01-01-2017 |
Eerdere bekende functies van David J. Maloney
Bedrijven | Functie | Einde |
---|---|---|
REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01-12-2017 |
Opleiding van David J. Maloney
University of Virginia | Doctorate Degree |
University of Vermont | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
REBUS HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |